Research Overview
What the peptide is
Thymosin beta-4 is a small, highly conserved intracellular protein whose principal known function is to bind monomeric G-actin and hold it in a sequestered pool, buffering the free actin available for filament assembly. TB-500 reproduces only the seven-residue stretch containing the actin-binding motif, with the N-terminus acetylated as it is in the native protein. Isolating the motif gives a molecule that is far cheaper to synthesise and easier to characterise analytically than the full protein.
Why a capsule format exists
Peptides are, as a class, poorly absorbed intact from the gastrointestinal tract: gastric acid, pepsin and pancreatic proteases degrade most sequences, and intestinal permeability to molecules of this size is limited. Short, modified peptides tend to fare better than long unmodified ones, and N-terminal acetylation removes one common site of aminopeptidase attack. A fixed-unit oral format lets investigators run that question directly — comparing oral and parenteral arms of the same peptide under otherwise identical conditions — rather than assuming an answer.
Research areas in the literature
- Fibroblast, endothelial and keratinocyte migration assays
- Dermal and corneal wound-closure models in rodents and rabbits
- Angiogenesis endpoints including endothelial tube formation
- Cardiac remodelling models following induced injury
- Pharmacokinetic and route-of-administration comparison studies
